Risa Kaneshige
Ube, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical Interpretation of Platelet Activation Marker sCLEC-2 in Antiphospholipid Syndrome.
Journal: Journal of clinical laboratory analysis
Published: January 27, 2026
Preliminary Evaluation of a Novel Lupus Anticoagulant Activity Assay Unaffected by Anticoagulants.
Journal: Journal of clinical laboratory analysis
Published: October 22, 2025
Antibody binding activity specific to monocyte scavenger receptor CD36 is frequently detectable in the plasma of patients with antiphospholipid syndrome.
Journal: Lupus
Published: September 16, 2023
Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching.
Thrombosis and antiphospholipid antibodies in Japanese COVID-19: based on propensity score matching.
Journal: Frontiers in immunology
Published: May 23, 2023
Determination of diagnostic threshold in harmonization and comparison of clinical utility for five major antiphospholipid antibody assays used in Japan.
Journal: Journal of clinical laboratory analysis
Published: October 13, 2021
Increased oxidative stress may be a risk factor for thromboembolic complications in patients with antiphospholipid syndrome.
Journal: Thrombosis research
Published: April 27, 2020
aCL/β2GPI and aPS/PT show synergic thrombogenic effects in suppressing anticoagulant activity of APC and stimulating tissue factor expression and TNF-α secretion by mononuclear cells.
Journal: Thrombosis research
Published: March 22, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026